| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.0043 | 1 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.00048 | 1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00044 | 1 |